MC38-hEpCAM
Strain Information
表現型データ
Fig1. hEpCAM expression on in vitro cultured cells of MC38-hEpCAM.
Fig2. In vivo validation of MC38-hEpCAM in C57BL/6 mice. C57BL/6 mice were inoculated with MC38-hEpCAM subcutaneously at 1×106 cells/mouse inoculum for tumor development.
Fig3. hEpCAM expression in tumors after in vivo growth of MC38-hEpCAM in wild type C57BL/6 mice. The tumors were collected at day 28 post tumor cell inoculation.
Fig4. hEpCAM expression in tumors after in vivo growth of MC38-hEpCAM in wild type C57BL/6 mice. The tumors were collected at day 37 post tumor cell inoculation.
関連の系統
あなたも好きかも
On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.
詳細Our vision is to provide researchers all over the world with comprehensive, convenient and professional animal model services to facilitate a simplified and highly-efficient approach towards uncovering the mysteries of life.
詳細